| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 303,000 | $487,830 | $1.61 | 03 Sep 2025 | Direct |
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7,500 | $12,075 | $1.61 | 03 Sep 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15,000 | 03 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Director | 04 Sep 2025, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 10 Jun 2025 | 1 | +$205,884 | 4 | Director | 12 Aug 2025, 16:30 |
| PLX | Protalix BioTherapeutics, Inc. | 29 Sep 2023 | 1 | $0 | 4 | Director | 03 Oct 2023, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 03 Jan 2023 | 1 | +$155,815 | 4 | Director | 05 Jan 2023, 16:08 |
| PLX | Protalix BioTherapeutics, Inc. | 07 Sep 2022 | 1 | $0 | 4 | Director | 09 Sep 2022, 17:02 |